ArticleFrontiers in medicine2023

Long-term efficacy and safety of guselkumab in Chinese patients with moderate-to-severe plaque psoriasis.

Jianfeng Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.